Effect of glycemic control on plasma plant sterol levels and post-heparin diamine oxidase activity in type 1 diabetic patients

Atherosclerosis

Volumn 145, Issue 2, 1999, Pages 389-397

  Kojima, Hideto ^a   Hidaka, Hideki ^a   Matsumura, Kazuhiro ^a   Fujita, Yukihiro ^a   Yamada, Syu ^a   Haneda, Masakazu ^a   Yasuda, Hitoshi ^a   Kikkawa, Ryuichi ^a   Kashiwagi, Atsunori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Sitosterol; Campesterol; Diamine oxidase; Lipoprotein; Plant sterol; Small intestine

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); CAMPESTEROL; CHOLESTEROL; GLYCOSYLATED ALBUMIN; HEPARIN; INSULIN; PENFIL N; PHYTOSTEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTESTINE ADAPTATION; LIPID ABSORPTION; LIPID METABOLISM; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AMINE OXIDASE (COPPER-CONTAINING); BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE TOLERANCE TEST; GLYCOSYLATION; HEPARIN; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOENZYME TECHNIQUES; INSULIN; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; PHYTOSTEROLS; SERUM ALBUMIN;

EID: 0032788265     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00070-2     Document Type: Article

References (43)

1. Howard BM. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
2. Ginsberg HN. Lipoprotein physiology in non-diabetic and diabetic states: relationship to atherosclerosis. Diabetes Care 1991;14:839-55.
3. Nikkila EA, Huttunen JK, Ehnholm C. Post-heparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus: relationship to plasma triglyceride metabolism. Diabetes 1977;26:11-21.
4. Taskinen MR, Nikkila EA. Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes: relation to high-density and very-low-density lipoproteins and response to treatment. Diabetologia 1979;17:351-6.
5. Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH. Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. New Engl J Med 1980;302:650-4.
6. Lopes-Virella MF, Wohltmann HJ, Loadholt CB, Buse MG. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia 1981;21:216-23.
7. Allen MG, August GP, Hung W. Relationship between control and serum lipids in juvenile-onset diabetes. Diabetes Care 1981;4:76-80.
8. The DCCT Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol 1995;75:894-903.
9. Kaufmann RL, Assal JP, Soeldner JS, Wilmshurst EG, Lemaire JR, Gleason RE, White P. Plasma lipid levels in diabetic children: effect of diet restricted in cholesterol and saturated fats. Diabetes 1975;24:672-9.
10. Gylling H, Miettinen TA. Cholesterol absorption and cholesterol and bile acid synthesis in two brothers with IDDM and diarrhea. Diabetes Care 1994;17:1345-7.
11. Wilson MD, Rudel LL. Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J Lipid Res 1994;35:943-55.
12. Ponz de Leon M, Iori R, Barbolini G, Pompei G, Zaniol P, Carulli N. Influence of small-bowel transit time on dietary cholesterol absorption in human beings. New Engl J Med 1982;307:102-3.
13. Färkkilä MA, Tilvis RS, Miettinen TA. Regulation of plasma plant sterol levels in patients with gut resections. Scand J Clin Lab Invest 1988;48:715-22.
14. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficacy in man is related to apoprotein E phenotype. J Clin Invest 1987;80:578-81.
15. Tilvis R, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986;43:92.
16. Sutherland WH, Scott RS, Lintott CJ, Robertson MC, Stapely SA, Cox C. Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. Horm Metab Res 1992;24:172-5.
17. Shedl HP, Wilson HD. Effect of diabetes on intestinal growth and hexose transport in the rat. Am J Physiol 1971;220:1739-45.
18. Fedorak RN, Chang EB, Field M. Intestinal adaptation to diabetes: altered Na-dependent nutrient absorption in streptozotocin-treated chronically diabetic rats. J Clin Invest 1987;79:1571-8.
19. Kojima H, Omoto Y, Hidaka H, Aoki T, Nakamura T, Kawabata T, Konaka K, Kashiwagi A, Kikkawa R, Shigeta Y. Increased plasma post-heparin diamine oxidase activity and plant sterol levels in streptozotocin diabetic rat. Biochem Biophys Res Commun 1992;186:398-404.
20. Kojima H, Hidaka H, Nakamura T, Konaka K, Matsumura K, Shigeta Y. Plasma post-heparin diamine oxidase activity in streptozotocin diabetic rats fed with different sterols. Atherosclerosis 1994;109:246 (abstracts).
21. Luk GD, Bayless TM, Baylin SB. Diamine oxidase (histaminase): a circulating marker for rat intestinal mucosal maturation and integrity. J Clin Invest 1980;66:66-70.
22. D'Agostino L, Ciacci C, Daniele B, Barone MV, Sollazzo R, Mazzacca G. Post-heparin plasma diamine oxidase in subjects with small bowel mucosa atrophy. Dig Dis Sci 1987;32:313-7.
23. D'Agostino L, Daniele B, Pallone F, Pignata S, Leoni M, Mazzacca G. Post-heparin plasma diamine oxidase in patients with small bowel Crohn's disease. Gastroenterology 1988;95:1503-9.
24. Rokkas T, Vaja S, Murphy GM, Dowling RH. Post-heparin plasma diamine oxidase in health and intestinal disease. Gastroenterology 1990;98:1493-501.
25. World Health Organization. Diabetes Mellitus: report of a WHO Study Group. World Health Organization Technical Report Series (Geneva) 1985;727.
26. Shima K, Ito N, Abe F, Hirota M, Yano M, Yamamoto Y, Uchida T, Noguchi K. High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia 1988;31:627-31.
27. Tryding N. Micromethod for the determination of plasma diamine oxidase. Scand J Clin Lab Invest 1965;17:197.
28. Okuyama T, Kobayashi Y. Determination of diamine oxidase activity by liquid scintillation counting. Arch Biochem Biophys 1961;95:242-50.
29. Ikeda Y, Takagi A, Ohkaru Y, Nogi K, Iwanga T, Kurooka S, Yamamoto A. A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human post-heparin plasma using monoclonal antibodies to the corresponding enzymes. J Lipid Res 1990;31:1911-24.
30. Kasama T, Byun DS, Seyama Y. Quantitative analysis of sterols in serum by high-performance liquid chromatography: application to the biochemical diagnosis of cerebrotendinous xanthomatosis. J Chromatogr 1987;400:241-6.
31. Hidaka H, Nakamura T, Aoki T, Kojima H, Nakajima Y, Kosugi K, Hatanaka I, Harada M, Kobayashi M, Tamura A, Fujii T, Shigeta Y. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis. J Lipid Res 1990;31:881-8.
32. The Expert Panel. Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36-69.
33. The DCCT, Research Group. Lipid and lipoprotein levels in patients with IDDM: diabetes control and complication trial experience. Diabetes Care 1992;15:886-94.
34. Dubrey SM, Reaveley DR, Seed M, Lane SD, Ireland H, O'Donnell M, O'Connor B, Noble MI, Leslie DG. Risk factors for cardiovascular disease in IDDM: a study of identical twins. Diabetes 1994;43:831-5.
35. Salen G, Ahrens EH Jr., Grundy SM. Metabolism of β-sitosterol in man. J Clin Invest 1970;49:952-67.
36. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990;131:20-31.
37. Omoto Y, Hidaka H, Kojima H, Shigeta Y. Evaluation of contribution of dietary sterols to hypercholesterolemia in streptozotocin-induced diabetic rats. J Japan Diab Soc 1994;37:335-42.
38. Miettinen TA, Vanhanen H. Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 1994;105:217-26.
39. Yuen CT, Easton D, Misch KJ, Rhodesand EL. Increased activity of serum amine oxidases in granuloma annulare, necrobiosis lipoidica and diabetes. Br J Dermatol 1987;116:643-9.
40. D'Agostino L, Ciacci C, Capuano G, Dniele B, D'Agostino G, Barone VM, Rodino S, Budillon G, Mazzaacca G. Metabolic fate of plasma diamine oxidase: evidence of isolated and perfused rat liver uptake. Digestion 1986;34:243-50.
41. Gang V, Baldus M, Kadereit M. Serum level changes of endogenous and post-heparin diamine oxidase (histaminase) in clinical and experimental hepatitis. Acta Hepatogastroenterol (Stuttg) 1976;23:104-9.
42. Bevilacqua E, Bombardieri G, Conti LR, Rossi L. Post-heparin plasmatic diamine oxidase (DAO) in chronic liver and kidney diseases. Quad Sclavo Diagn 1980;15:1026-32.
43. Kojima H, Hidaka H, Matsumura K, Fujita Y, Nishio Y, Maegawa H, Haneda M, Yasuda H, Fujimiya M, Kikkawa R, Kashiwagi A. Concerted regulation of early enterocyte differentiation by insulin-like growth factor I, insulin, and transforming growth factor-β1. Proc Assoc Am Physicians 1998;110:197-206.